Osimertinib Mesylate Tablets
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Osimertinib Mesylate Tablets, covering 2025-09-19 to 2025-09-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study of BL-B01D1 and BL-B01D1 in Combination With Osimertinib Mesylate Tablets in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer [Phase 2]